The House of Representatives’ version of the healthcare reform bill, dubbed the America’s Affordable Health Choices Act of 2009, includes the provisions of the Physician Payment Sunshine Act, which would mandate sweeping transparency measures for pharmas.
The legislation would require companies to report all grants to CME providers, though reporting of attendees and expenses would not be required. An earlier version of the legislation drew the support of Lilly and other drugmakers. The House version includes language establishing federal pre-emption for collecting information covered by the bill, meant to increase public disclosure of payments.
From the August 01, 2009 Issue of MM+M - Medical Marketing and Media
